Prabhu, A., Kant, S., Kesarwani, P., Ahmed, K., Forsyth, P., Nakano, I., & Chinnaiyan, P. (2018). CBMT-18. INTEGRATIVE CROSS PLATFORM ANALYSES IDENTIFY ENHANCED HETEROTROPHY AS A METABOLIC HALLMARK IN GLIOBLASTOMA. Neuro Oncol.
Style de citation ChicagoPrabhu, Antony, Shiva Kant, Pravin Kesarwani, Kamran Ahmed, Peter Forsyth, Ichiro Nakano, et Prakash Chinnaiyan. "CBMT-18. INTEGRATIVE CROSS PLATFORM ANALYSES IDENTIFY ENHANCED HETEROTROPHY AS A METABOLIC HALLMARK IN GLIOBLASTOMA." Neuro Oncol 2018.
Style de citation MLAPrabhu, Antony, et al. "CBMT-18. INTEGRATIVE CROSS PLATFORM ANALYSES IDENTIFY ENHANCED HETEROTROPHY AS A METABOLIC HALLMARK IN GLIOBLASTOMA." Neuro Oncol 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.